The CD65 antigen is analogous to the carbohydrate structure(s) recognized by CD15 antibodies. It is a type II chain fucoganglioside involving the oligosaccharide sequence : Galβ1 - 4GlcNacβ1 - 3Galβ1 - 4GlcNac(Fucα1-3)β1 - R. Granulocytes are CD65 positive and monocytes are weakly positive. It does not react with T and B lymphocytes.

Specifications

Specificity CD65
Form FITC
Clone 88H7
Flow Product Line IOTest
Clone Description 88H7 antibody was re-assigned from the CD65s to the CD65 cluster during HLDA 6.
Isotype IgM Mouse
Format Liquid
Size 2 mL
Regulatory Status ASR
Target Species Human
Other Names CD65, Ceramide dodecasaccharide 4c, fucoganglioside type II, VIM2
UNSPSC 41116015

NOT ALL PRODUCTS ARE AVAILABLE IN ALL COUNTRIES
PRODUCT AVAILABILITY AND REGULATORY STATUS DEPENDS ON COUNTRY REGISTRATION PER APPLICABLE REGULATIONS

The listed regulatory status for products correspond to one of the below:
IVD: In Vitro Diagnostic Products. These products are labeled "For In Vitro Diagnostic Use."
ASR: Analyte Specific Reagents. These reagents are labeled "Analyte Specific Reagents. Analytical and performance characteristics are not established."
CE: Products intended for in vitro diagnostic use and conforming to European Directive (98/79/EC). (Note: Devices may be CE marked to other directives than (98/79/EC)
RUO: Research Use Only. These products are labeled "For Research Use Only. Not for use in diagnostic procedures."
LUO: Laboratory Use Only. These products are labeled "For Laboratory Use Only."
No Regulatory Status: Non-Medical Device or non-regulated articles. Not for use in diagnostic or therapeutic procedures.